Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Shares Issued (2016 - 2024)

Xtant Medical Holdings (XTNT) has disclosed Shares Issued for 12 consecutive years, with -$4.4 million as the latest value for Q4 2024.

  • On a quarterly basis, Shares Issued changed N/A to -$4.4 million in Q4 2024 year-over-year; TTM through Dec 2024 was -$1.5 million, a 149.6% decrease, with the full-year FY2024 number at $13000.0, down 99.91% from a year prior.
  • Shares Issued was -$4.4 million for Q4 2024 at Xtant Medical Holdings, down from $3.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $18.4 million in Q1 2021 to a low of -$4.4 million in Q4 2024.
  • A 3-year average of $4.2 million and a median of $1.5 million in 2021 define the central range for Shares Issued.